India Agency To Cite Drug Makers Who Keep Brand Without API
This article was originally published in PharmAsia News
Executive Summary
India’s National Pharmaceutical Pricing Authority plans to take action against drug makers it says remove active pharmaceutical ingredients under price controls from their drugs while maintaining the brand name.